Measurement of Cardiac Output Before and After Cardiopulmonary Bypass.
NCT ID: NCT01103895
Last Updated: 2016-05-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
14 participants
OBSERVATIONAL
2007-07-31
2012-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cardiac Output Measurement at the Conclusion of Cardiopulmonary Bypass
NCT01103908
Measurement of Cardiac Output and Blood Volumes Using Transonic Ultrasound Dilution Technology
NCT00756119
Accurate Measurement of Cardiac Output Using the Ultrasound Dilution Technique
NCT00851422
Validation of Minimally Invasive Ultrasound Indicator Dilution Technique in Critically Ill Children
NCT00852254
Validation of Automated Cardiac Output Measurement
NCT03372863
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients undergoing surgery involving cardiopulmonary bypass
* Patients instrumented with a thermodilution catheter
Exclusion Criteria
* Patients undergoing surgery "off pump" (not involving cardiopulmonary bypass)
21 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Heart, Lung, and Blood Institute (NHLBI)
NIH
Transonic Systems Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Nikolai Krivitski, PhD, DSc
Role: PRINCIPAL_INVESTIGATOR
Transonic Systems Inc.
Edward P Nast, MD
Role: PRINCIPAL_INVESTIGATOR
Arnot Ogden Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Arnot Ogden Medical Center
Elmira, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
TSI-C-HCE101-4A-H
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.